Research location
Hull
United Kingdom
Advertisement
Research activity in Hull
United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 149 trials and 151 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Hull
149 linked trials · page 1 of 3A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusNCT07776509 · 2026-08-24 · 1 site observation
RECRUITING
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsNCT07797335 · 2026-08-24 · 1 site observation
RECRUITING
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or OverweightNCT07784270 · 2026-08-20 · 1 site observation
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background DapagliflozinNCT07662135 · 2026-07-06 · 1 site observation
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesNCT07351058 · 2026-03-23 · 1 site observation
RECRUITING
Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation RiskNCT07067658 · 2025-12-18 · 1 site observation
RECRUITING
Targeted Abdominal CT in Conjunction With Lung Cancer ScreeningNCT07171190 · 2025-11-11 · 1 site observation
RECRUITING
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerNCT06793215 · 2025-10-24 · 1 site observation
RECRUITING
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)NCT06760546 · 2025-09-23 · 1 site observation
RECRUITING
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation
RECRUITING
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung CancerNCT06868277 · 2025-04-10 · 1 site observation
RECRUITING
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)NCT06672549 · 2024-11-18 · 1 site observation
RECRUITING
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related ComorbiditiesNCT06672939 · 2024-11-18 · 1 site observation
RECRUITING
Hemithoracic Irradiation With Proton Therapy in Malignant Pleural MesotheliomaNCT05655078 · 2024-03-28 · 1 site observation
RECRUITING
Biological Matrices Versus Synthetic MeshesNCT05449691 · 2023-11-02 · 1 site observation
RECRUITING
IIH Intervention: A Clinical Trial Comparing 2 Treatments (Shunts and Stents) Evaluation Of Clinical Effectiveness And Cost EffectivenessNCT07440277 · 2023-07-18 · 1 site observation
RECRUITING
The "Global Paradise System" RegistryNCT05027685 · 2022-01-13 · 1 site observation
RECRUITING
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant ChemotherapyNCT04109079 · 2021-02-26 · 1 site observation
RECRUITING
The European NAFLD RegistryNCT04442334 · 2015-05-01 · 1 site observation
RECRUITING
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 DiabetesNCT07668336 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical PracticeNCT07055607 · 2025-05-01 · 1 site observation
ENROLLING_BY_INVITATION
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightNCT06858878 · 2025-03-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are OverweightNCT06858839 · 2025-03-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)NCT05646199 · 2025-03-01 · 1 site observation
UNKNOWN
A Study in Participants With Obesity or Overweight With at Least One Weight-related ComorbidityNCT06595238 · 2024-10-01 · 1 site observation
COMPLETED
HF-TRACK: A UK RCT of an Passive Heart Failure Monitoring and Tracking DeviceNCT06334822 · 2024-07-11 · 3 site observations
ACTIVE_NOT_RECRUITING
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)NCT06383390 · 2024-04-30 · 1 site observation
ACTIVE_NOT_RECRUITING
SAFE-LCD Trial, for Insulin-treated Adults Living With Type 2 DiabetesNCT06119204 · 2024-01-26 · 1 site observation
TERMINATED
CGM Use in Adults With Type 2 Diabetes on Basal InsulinNCT05944432 · 2023-07-14 · 1 site observation
ACTIVE_NOT_RECRUITING
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid ArthritisNCT05848258 · 2023-05-23 · 1 site observation
COMPLETED
A Trial of Setmelanotide in Acquired Hypothalamic ObesityNCT05774756 · 2023-04-26 · 1 site observation
ACTIVE_NOT_RECRUITING
FreeStyle Libre Monitoring in T2DMNCT05597293 · 2023-02-27 · 1 site observation
COMPLETED
Open-Label Extension Study of DCCR in Patients With Prader-Willi SyndromeNCT05701774 · 2023-01-31 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With ObesityNCT05556512 · 2022-10-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Tracking Treatment Pathways in Adult Patients With Hyperkalemia.NCT05408039 · 2022-07-14 · 1 site observation
COMPLETED
Niraparib Efficacy in Patient With Unresectable MesotheliomaNCT05455424 · 2022-07-11 · 1 site observation
COMPLETED
Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes MellitusNCT05232071 · 2022-06-29 · 1 site observation
COMPLETED
Extracorporeal Shockwave Therapy for Diabetic Foot UlcersNCT05380544 · 2022-04-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With DiabetesNCT05009602 · 2022-03-14 · 1 site observation
COMPLETED
HbA1c Variation StudyNCT05189938 · 2021-12-20 · 1 site observation
COMPLETED
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung CancerNCT05091567 · 2021-11-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Benralizumab Patient Access Programme Study: Retrospective Study in UK Severe Asthma CentresNCT05932849 · 2021-10-05 · 1 site observation
COMPLETED
A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to MethotrexateNCT04909801 · 2021-09-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)NCT04609904 · 2021-03-01 · 1 site observation
COMPLETED
PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -VNCT04870333 · 2021-02-19 · 1 site observation
COMPLETED
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.NCT04564742 · 2020-12-22 · 1 site observation
COMPLETED
A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung CancerNCT04619797 · 2020-12-15 · 1 site observation
COMPLETED
RELieving Increasing oEdema Due to Heart FailureNCT04142788 · 2020-08-26 · 1 site observation
TERMINATED
AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19NCT04516759 · 2020-08-12 · 1 site observation
COMPLETED
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With OlaparibNCT04421963 · 2020-08-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.